Oct 29, 202643 min
RetinUp turns one year old. Before the birthday reflections, John Kitchens, MD, and Scott Krzywonos take stock of what the past eighteen months of retina acquisitions actually mean: Merck’s purchase of EyeBio for up to...
About this Podcast:
RetinUp is a podcast exploring the latest in retina science and ophthalmology. Hosted by John Kitchens, MD, and Scott Krzywonos, each episode features expert insights, research breakthroughs, and practical discussions designed for ophthalmologists, retina specialists, and vision science researchers.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
31%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for RetinUp Podcast.
Signup to Generate a PitchQuestions about RetinUp Podcast
What is RetinUp Podcast about?
RetinUp is a podcast exploring the latest in retina science and ophthalmology. Hosted by John Kitchens, MD, and Scott Krzywonos, each episode features expert insights, research breakthroughs, and practical discussions designed for ophthalmologists, retina specialists, and vision science researchers.
What has RetinUp Podcast covered recently?
Recent episodes include "Big Pharma’s Retina Bets | Don D’Amico, MD, on BRUNELLO | RetinUp Turns One" (29 October 2026, 43 minutes), "Breaking News: Alcon Acquires Neurotech" (21 October 2026, 12 minutes), and "Breaking News: LUCIA Misses in Wet AMD, EyePoint Shifts to DME" (19 October 2026, 8 minutes).
How often does RetinUp Podcast publish?
RetinUp Podcast publishes roughly a few times a week, with episodes averaging 26 minutes.
How hard is it to get booked on RetinUp Podcast?
Booking probability for RetinUp Podcast is 31%, and the host is rated Selective on guests. RetinUp Podcast requires a Pod Score of 80 or higher. RetinUp Podcast's contact route on record: verified email.
Who should pitch RetinUp Podcast?
The strongest fits for RetinUp Podcast are Doctors & Physicians. RetinUp Podcast has a health audience and around 160 subscribers on YouTube.
About the host
RetinUp Podcast is a health podcast.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #36
Breaking News: Alcon Acquires Neurotech
Oct 21, 202612 minTwo pieces of news today, October 21, 2026. Alcon announced the acquisition of Neurotech Pharmaceuticals for $550 million upfront, with additional milestone payments possible. John Kitchens, MD, and Scott Krzywonos...
Oct 19, 20268 minBreaking news: EyePoint Pharmaceuticals announced this morning that LUCIA, the second pivotal Phase 3 trial of Duravyu (vorolanib, EYP-1901) for wet AMD, did not achieve the primary endpoint of statistical...
Oct 15, 202642 minJohn Kitchens, MD, and Scott Krzywonos recap the American Academy of Ophthalmology 2026 Annual Meeting in New Orleans — a meeting that delivered on science even as a hurricane threatened attendance. Zenkuda’s 6-month...
Oct 1, 202622 minJohn Kitchens, MD, and Scott Krzywonos take stock of the biggest retina data readouts of 2026 — from a superiority study from Ocular Therapeutix to a Kodiak comeback and a gene therapy from Beacon that could be the...
View More
Sep 28, 20268 minBreaking news: Kodiak Sciences announced this morning that both Zenkuda (tarcocimab tedromer) and tabirafusp-ted (KSI-501, tabirafusp alfa tedromer) met their primary endpoints in the Phase 3 DAYBREAK study in wet AMD —...
Sep 25, 202613 minBreaking news: Merck announced this morning that remigromig (MK-3000), its investigational tetravalent tri-specific Wnt pathway agonist, met the primary endpoint of the Phase 2b/3 BRUNELLO trial for diabetic macular...
Sep 23, 202611 minBreaking news: Beacon Therapeutics announced positive topline data from the VISTA pivotal trial of laru-zova (laruparetigene zovaparvovec) for X-linked retinitis pigmentosa (XLRP) — the first gene therapy trial in XLRP...
- Sep 17, 202636 min
John Kitchens, MD, and Scott Krzywonos break down the AAO 2026 annual meeting in New Orleans (October 9–12) — whether it still matters, what to catch at Subspecialty Day, and which late-breaking Phase 3 data...
Sep 3, 202638 minJohn Kitchens, MD, and Scott Krzywonos take stock of the three biggest retina news stories of 2026 — the SOL-1 superiority data for Axpaxli (Ocular Therapeutix), the FDA approval of Lytenava (Outlook Therapeutics), and...
Aug 20, 202641 minJay S. Duker, MD, President & CEO of EyePoint Pharmaceuticals, joins John and Scott to parse the LUGANO Phase 3 topline data — just three days after release. He walks through Duravyu's MOA, what the nine outlier...
Aug 17, 20269 minBreaking news: EyePoint Pharmaceuticals announced LUGANO Phase 3 topline data this morning. Duravyu, an investigational sustained-release TKI for wet AMD, did not meet its primary non-inferiority endpoint in the full...
Aug 13, 202629 minThe companion piece to RetinUp’s previous episode on biosimilars is here, featuring an oncologist who has lived through biosimilar disruption for the past decade. Stephen "Fred" Divers, MD, CMO of the American Oncology...
Jul 25, 20267 minBreaking news: the US Food and Drug Administration approved Lytenava (bevacizumab-vikg, Outlook Therapeutics) on July 24, 2026 — making it the first and only FDA-approved ophthalmic formulation of bevacizumab for the...
Jul 23, 202631 minShow Notes: Guests: Devon Ghodasra, MD – Partner, Southeastern Retina Associates, Chattanooga, Tennessee Vas Sadda, MD – Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute; Professor of...
Jul 9, 202624 minJorge Fortun, MD, of Bascom Palmer Eye Institute joins John Kitchens, MD, and Scott Krzywonos for a wide-ranging conversation on the art of retina practice, from the unique challenges of seeing highly educated...
Jun 25, 202636 minGuests: Hunter Cherwek, MD – Vice President, Clinical Services & Technologies, Orbis International Frank Brodie, MD, MBA – Assistant Professor of Ophthalmology, UCSF; Co-Founder, Long Bridge Medical Show Summary Hunter...
Jun 11, 202630 minGuests: John B. Miller, MD – Associate Professor of Ophthalmology, Harvard Medical School; Director of Retinal Imaging; Associate Fellowship Director, Vitreoretinal Surgery, Mass Eye and Ear Show Summary John Kitchens...
May 28, 202631 minS0<p>John Kitchens, MD, joins from Kiawah Island for the inaugural Kiawah Eye Retina meeting as he and Scott Krzywonos break down two pressing policy stories: what the GLOBE Project actually means for retina practices...
May 14, 202649 minS0<p>Guests: Marci English, MPH – Senior Vice President, Biopharma and Ophthalmology Development, Astellas Pharma | Erin Kimbrel, PhD – President, Astellas Institute for Regenerative Medicine (AIRM); Head of Cell and Gene...
Recent guests
Recent guests on RetinUp Podcast. Study who booked and why before you pitch.
J
John Kitchens, MD
real estate coach and systems strategist, Retina Associates of Kentucky Eye Care Partners
C
Christina Y. Weng
Professor & Alice R. McPherson Retina Research Foundation Chair in Ophthalmology at Baylor College of Medicine, Baylor College of Medicine
M
Murtaza Adam
Chair of Clinical Research, Colorado Retina Associates
D
David Mandell
attorney, MBA, wealth strategist, The Law Office of David B. Mandell, PC
Best industries to pitch RetinUp Podcast for
PitchCentric classifies RetinUp Podcast under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like RetinUp Podcast
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ